Voyager Therapeutics, Inc. (VYGR)
NASDAQ: VYGR · Real-Time Price · USD
3.540
+0.240 (7.27%)
At close: Jun 6, 2025, 4:00 PM
3.600
+0.060 (1.69%)
Pre-market: Jun 9, 2025, 7:00 AM EDT

Voyager Therapeutics Stock Forecast

Stock Price Forecast

According to 6 professional analysts, the 12-month price target for Voyager Therapeutics stock ranges from a low of $7.00 to a high of $30. The average analyst price target of $14.33 forecasts a 304.80% increase in the stock price over the next year.

Price Target: $14.33 (+304.80%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $7.00 $14.33 $12 $30
Change +97.74% +304.80% +238.98% +747.46%
* Price targets were last updated on Apr 8, 2025.

Analyst Ratings

The average analyst rating for Voyager Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 554333
Buy 335554
Hold 111111
Sell 000000
Strong Sell 000000
Total 9910998

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +747.46% Apr 8, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$14$12
Strong Buy Maintains $14$12 +238.98% Mar 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +747.46% Mar 13, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$12$10
Buy Maintains $12$10 +182.49% Mar 12, 2025
Wedbush
Wedbush
Buy
Reiterates
n/a
Buy Reiterates n/a n/a Mar 12, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
48.49M
from 80.00M
Decreased by -39.39%
Revenue Next Year
70.47M
from 48.49M
Increased by 45.34%
EPS This Year
-2.16
from -1.13
EPS Next Year
-1.36
from -2.16
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
171.13M37.42M40.91M250.01M80.00M48.49M70.47M72.93M
Revenue Growth
63.93%-78.14%9.33%511.16%-68.00%-39.39%45.34%3.50%
EPS
0.98-1.89-1.212.97-1.13-2.16-1.36-1.52
EPS Growth
--------
Forward PE
--------
No. Analysts
-----141411
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 154.0M 168.0M 129.0M
Avg 48.5M 70.5M 72.9M
Low 9.3M 9.3M 9.3M

Revenue Growth

Revenue Growth 20252026202720282029
High
92.5%
246.4%
83.0%
Avg
-39.4%
45.3%
3.5%
Low
-88.4%
-80.9%
-86.8%

EPS Forecast

EPS 20252026202720282029
High -1.66 2.10 -0.84
Avg -2.16 -1.36 -1.52
Low -2.89 -2.85 -2.04

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.